About: Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $13.41 (-4.69%)
JBIO NASDAQ Jade Biosciences, Inc.
Jade Biosciences, Inc. share price
JBIO price activity
Último preço
$ 13,410
Variação (24h)
-0,66 USD (-4,69%)
Volume
491.82K
Volume (média 4 sem.)
-
Abertura
$ 14,20
Variação do dia
$ 13,15 - $ 14,34
Fechamento anterior
$ 14,07
Último negócio
06 Oct, 8:27 pm GMT+0
Atrasado
06 Oct, 8:27 pm GMT+0
JBIO price performance
Atrasado
06 Oct, 8:27 pm GMT+0
quote.marketSignals